BioSpace News Archive

CytoDyn Inc. (OTCQB: CYDY) (“CytoDyn” or the “Company”), today announced that its CRO in Brazil (Academic Research Organization (ARO) Albert Einstein Israelite Hospital (AEIH)) met with the Brazilian Health Regulatory Agency (ANVISA) and received its agreement to modify the CD16 trial for critically ill COVID-19 patients.

SRI Biosciences has been awarded a $14.7 million contract sponsored by the Defense Threat Reduction Agency through the Medical, Chemical, Biological, Radiological, and Nuclear Defense Consortium to continue development of a high-concentration naloxone product for intravenous, intramuscular and subcutaneous injection, or intravenous infusion.

Radius Health, Inc. announced it will host a conference call , Wednesday, December 8, 2021, at 4:00 p.m. ET to cover the below.

Inspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN, IINNW) (the “Company” or “Inspira Technologies”), announced today it has filed a Patent Cooperation Treaty (PCT) patent application for its novel ART device and its proprietary methods of use to minimize the need for invasive mechanical ventilation which requires intubation and induced coma.

ZymoChem, Inc., an early-stage bioproducts company engineering microbial-based processes for manufacturing industrial chemicals and crafting high-performance materials, today announced that it has closed a $4 million Seed financing.

Adial Pharmaceuticals, Inc. today announced the appointment of Cary J. Claiborne as Chief Operating Officer. Mr. Claiborne will continue to serve on the Board of Directors.

Novartis today announced new Kisqali® (ribociclib) data demonstrating a consistent overall survival (OS) benefit with Kisqali plus endocrine therapy (ET) across genomic subtypes of hormone receptor positive, human epidermal growth factor receptor-2 negative (HR+/HER2-) advanced or metastatic breast cancer (mBC), similarly in the indolent as well as in the aggressive, endocrine therapy (ET)-resistant subtypes.

The Lupus Foundation of America announced the recipients of its most prestigious annual awards, naming Richard A. Furie, MD, Northwell Health as this year’s Evelyn V. Hess Award recipient and Melissa Cunningham, MD, PhD, The Medical University of South Carolina as the Mary Betty Stevens Young Investigator Prize award winner.

Herophilus today announced that the company is expanding its scientific advisory board with the appointment of Kenneth S. Kosik, M.A., M.D.

Essence Group today announced it will showcase the world’s first 5G-enabled mobile personal emergency response system (mPERS) at CES 2022 in January.